dc.contributor.author |
Khalil, Bariaa Ahmad. |
dc.date.accessioned |
2012-06-13T07:36:04Z |
dc.date.available |
2012-06-13T07:36:04Z |
dc.date.issued |
2012 |
dc.identifier.uri |
http://hdl.handle.net/10938/8847 |
dc.description |
Thesis (M.S.)--American University of Beirut, Department of Biology, 2012.;"Advisor : Dr. Nadine Darwiche, Professor, Biochemistry and Molecular Genetics--Members of Committee : Dr. Ali Bazarbachi, Professor, Internal Medicine Dr. Hala Gali-Muhtasib, Pr |
dc.description |
Includes bibliographical references (leaves 72-77) |
dc.description.abstract |
E-3-(40-Hydroxy-30-adamantylbiphenyl-4-yl)acrylic acid (ST1926) is a novel orally available synthetic retinoid that is currently in phase I clinical trials. Synthetic retinoids are a group of compounds with Vitamin A activity that have promising anti-can |
dc.format.extent |
xvii, 78 leaves : ill. (some col.) 30 cm. |
dc.language.iso |
eng |
dc.relation.ispartof |
Theses, Dissertations, and Projects |
dc.subject.classification |
T:005590 AUBNO |
dc.subject.lcsh |
Retinoids. |
dc.subject.lcsh |
HTLV-I (Virus) |
dc.subject.lcsh |
Adult T-cell leukemia. |
dc.subject.lcsh |
Cell death. |
dc.subject.lcsh |
T cells. |
dc.subject.lcsh |
Cancer cells. |
dc.title |
Mechanisms of cell death and retinoid signaling induced by the novel synthetic retinoid ST1926 in HTLV-1 transformed and malignant T-cells - by Bariaa Ahmad Khalil. |
dc.type |
Thesis |
dc.contributor.department |
American University of Beirut. Faculty of Arts and Sciences. Department of Biology. |